Fox Business - The Power to Prosper
Search Site


The hot health care stocks to buy now for your 401(K)

FBN’s Charles Payne, Divine Capital CEO Dani Hughes, A&G Capital CIO Hilary Kramer, FBN contributor Anthony Scaramucci, Tea Party News Network News Director Scottie Nell Hughes and Penn Financial Group founder Matt McCall on the opportunities for investors in health care.

Read More

  1. Two cases for a bullish market outlook

    Eagle Bay Capital founder J.C. Parets and Zor Capital Managing Director Joe Fahmy on the outlook for the markets.

  2. Should you buy ‘sin’ stocks?

    FBN’s Charles Payne, Douglas C. Lane & Associates’ Matthew Veto, Fairfax Global Markets CEO Paul Dietrich, A&G Capital CIO Hilary Kramer, retail analyst Hitha Herzog and Penn Financial Group founder Matt McCall on investing in ‘sin’ stocks.

  3. Lackluster earnings so far

    NRF Vice President Jonathan Gold discusses the economic impact of a full port shutdown.

  4. Changing DNA of the future

    Former Pennsylvania Congressman Jim Greenwood discusses what he sees moving the needle on DNA patentability.

  5. Genetic testing made easy

    Recombine CEO Alexander Bisignano discusses how his company is trying to improve genetic testing.

  6. Hospira, Pfizer a good deal?

    Ariel Investments Vice Chairman Charles Bobrinskoy discusses the deal between Pfizer and Hospira and how he’s allocating capital.

  7. Pfizer eyes growth in biosimilar injectable market

    Canaccord Genuity U.S. Portfolio Strategist Tony Dwyer and Glenmede Director of Investment Strategy Jason Pride discuss money flow into the health-care sector.

  8. Pfizer buys Hospira

    FBN’s Liz MacDonald on Pfizer’s multi-billion dollar bet on Hospira.

  9. Without Apple, growth looks a lot slower

    JPM Private Bank Global Equity Strategy Head Steven Rees, Argus Research President John Eade and Skybridge Founder Anthony Scaramucci discuss earnings growth and how to allocate capital.

  10. OPKO Health shares a ‘buy’ despite high risks?

    FBN’s Charles Payne, BNP Paribas Cash Equity Trading Head Darren Wolfberg A&G Capital CIO Hilary Kramer, NewOak Capital President James Frischling and Penn Financial Group founder Matt McCall on the outlook for OPKO Health.

  11. Best place for your money

    M.D. Sass CEO Martin Sass and Lido Isle Advisors CEO Jason Rotman break down money buys for portfolio.

  12. Priceline founder taps into innovation

    Priceline Founder Jay Walker on launching a managing patent service.

  1. When will the Fed hike rates?

    U.S. Bank Wealth Management Senior Portfolio Manager Eric Wiegand and Veracruz LLC Founder Steve Cortes discuss their outlook for the Fed, rate hikes and the markets.

  2. In which small caps should you invest?

    FBN’s Cheryl Casone, Portfolio Wealth Advisors Co-Founder Lee Munson and Kaltbaum Capital Management President Gary Kaltbaum on where to invest as the Russell 2000, putting money in small caps and the homebuilders industry.

  3. Cure for peanut allergies?

    Dr. Kevin Campbell of the UNC Department of Medicine discusses two new studies that may be game changers for people with peanut allergies.

  4. U.S. cash flowing overseas

    RJ O’Brien Managing Director John Brady and S&P Capital IQ Managing Director Mike Thompson discuss the corporate tax debate and where they would put money in today’s market.

  5. Did Greece boost the U.S. stock record rally?

    FBN’s Deirdre Bolton, A&G Capital CIO Hilary Kramer, NewOak Capital President James Frischling, Tea Party News Network News Director Scottie Nell Hughes and Penn Financial Group founder Matt McCall on Greece’s impact on the U.S. markets.

  6. Will the Nasdaq pass 5K?

    Barron’s Editor and President Ed Finn discusses the magazine’s cover story of America’s top 1,200 financial advisors, the Nasdaq’s run at 5K and Apple stock.

  7. Europe headed for a Grexit?

    OppenheimerFunds Chief Economist Jerry Webman and GFI Group’s John Spallanzani discuss the ECB minutes, the Greek debt crisis and the tech and airline sectors.

‹ Prev12345Next ›
Freebase CC-BY
Source: Biotechnology on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL